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Evaluation of correlation between serum levels of Decoy receptor 3 and IL-6 
with echocardiography and angiography finding in acute myocardial 




Bakground and objective: Cardiovascular diseases are among leading causes of mortality 
worldwide.  Some risk facors are hyperlipidemia, smoking and familial history. DcR3 is a 
member of TNFRSF superfamily which has probable affects on atherosclerosis due to its effects 
on inflammation process.  
Methods: In this case-control study, 3 groups, each including 30 people were enrolled. First 
group was containing AMI patients, second group was containing SAP patients and third group 
was containing healthy individuals. Demographic, Echocardiographic, laboratory findings (such 
as DcR3 and IL-6) were gathered and been analysed. 
Results: The results suggested that DcR3 levels was significantly higher in AMI patients as well 
as IL-6. also, EFT and EFT index were higher in AMI patients compared to the SAP and control 
group. More evaluations reveald a significant correlation between DcR3 with CK-MB, HsTnT, 
Gensini score, EFT, WBC count and IL-6 levels. also, a reverse correlation was found between 
DcR3 with LVEF and e' Lateral. 
Conclusions: In conclusion, the current study revealed a positive association of DcR3 with EFT 
for the first time in AMI patients. In addition, these results represent a relationship between 
DcR3 and IL-6, WBC count, CK-MB, troponin-T, Gensini, and LVEF. Various factors such as 
atherosclerosis are involved in the pathogenesis of CAD. It has been suggested that an increase 
in DcR3 through inflammation may influence the process of atherosclerosis. Although this study 
does not show the causal link between DcR3 and CAD in patients with AMI, it suggests a role for 
DcR3 in these patients. 
Keywords: Decoy  Receptor 3, Myocardial infarction, Interleukin 6 
 
